文献速递心血管US

运动试验在肥厚型心肌病中的作用

Role of Exercise Testing in Hypertrophic Cardiomyopathy.
PubMed 文献 · JACC Cardiovasc Imaging · 2017-01-01

过去25年,运动试验被用于肥厚型心肌病患者,对疾病管理有重要贡献且不增加风险。运动超声心动图已纳入标准临床评估,可用于诱发无静息流出道梗阻患者的梗阻、预测心力衰竭症状进展、区分可诱发梗阻与无梗阻患者以指导治疗选择;代谢运动试验可独立定量评估功能受限并指导心脏移植资格;运动低血压反应可辅助风险分层。

要点

  • 运动超声心动图是诱发无静息流出道梗阻患者梗阻的最合适方法,可区分可诱发梗阻与无梗阻。
  • 运动超声心动图能预测未来进展性心力衰竭症状的发生,对治疗选择有重大意义。
  • 代谢运动试验降低的心肌氧耗可独立定量评估功能受限,并指导心脏移植资格。

核心结论

  • 多种方法的运动试验已成为肥厚型心肌病无创评估的组成部分,对部分患者可决定治疗策略。

研究设计与样本

  • 综述性文章,总结过去25年肥厚型心肌病患者采用生理运动的各种方法研究。

临床应用与阅片要点

  • 对无静息流出道梗阻的肥厚型心肌病患者,运动超声心动图是诱发梗阻的最合适方法。
  • 运动超声心动图可区分可诱发梗阻与无梗阻患者,对决定手术室间隔心肌切除术(或酒精室间隔消融)与心脏移植有重大意义。
  • 代谢(心肺)运动试验通过降低的心肌氧耗独立定量评估功能受限,并指导心脏移植资格。
  • 运动低血压反应可作为风险分层决策的仲裁者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Over the last 25 years, patients with hypertrophic cardiomyopathy (HCM) have been studied with a variety of methods employing physiological exercise that have made major contributions to disease management and are performed without increased risk. Previously under-utilized in HCM, exercise (stress) echocardiography has become incorporated into the standard clinical assessment and diagnostic armamentarium of HCM using upright or supine symptom-limited treadmill or bicycle modalities. In patients without outflow gradients at rest, exercise echocardiography is the most appropriate method for provoking obstruction, with the capability of predicting future development of progressive heart failure symptoms, and differentiating patients with provocable obstruction from those without obstruction, with major implications for dictating treatment options, that is, surgical myectomy (alternatively, alcohol septal ablation) versus heart transplant. Reduced myocardial oxygen consumption with metabolic (cardiopulmonary) exercise testing provides an independent and quantitative assessment of functional limitation for individual patients when the personal history is ambiguous, and also guides eligibility for heart transplant. Hypotensive blood pressure response to exercise can be an arbitrator in risk stratification decisions. Exercise testing with a variety of methods has become an integral and powerful component of the noninvasive evaluation of HCM, and in some patients can determine treatment strategy.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Rowin EJ, Maron BJ, Olivotto I, et al. Role of Exercise Testing in Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2017. PMID: 29122139. doi:10.1016/j.jcmg.2017.07.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。